Nippon Gases Deploys Juniper Networks’ AI-Native Networking Platform to Foster Growth and Accelerate Innovation
12.12.2024 09:00:00 CET | Business Wire | Press release
New wired and wireless network consolidates and transforms operations to underpin mission-critical gas production across Europe
Juniper Networks®, (NYSE: JNPR), a leader in secure, AI-Native Networking, today announced that Nippon Gases, one of the largest industrial gas companies in Europe, has implemented Juniper’s AI-Native wired and wireless LAN solutions to enhance mobile experiences across Nippon Gases’s IT and operational technology (OT) environments whilst streamlining network operations to foster digital innovation. As a key element of Juniper’s AI-Native Networking Platform, the new infrastructure uses Mist AI and cloud native capabilities to provide industry-leading efficiency, resiliency and visibility to Nippon Gases, resulting in exceptional user and operator experiences across offices, specialty labs, manufacturing plants, trucks, pipelines and ships.
With operations in 13 countries, Nippon Gases produces essential gases such as oxygen, nitrogen, hydrogen and carbon dioxide, serving multiple industries including healthcare, food and beverage, manufacturing and biotech.
By standardizing on Juniper’s unique AI for networking capabilities, Nippon Gases accelerates service deployment, simplifies operations, reduces total cost of ownership (TCO) and operational expenses, delivering exceptional end-to-end user and IT experiences. Additionally, Juniper’s AI-Native Networking Platform will help Nippon Gases accelerate new site set ups, increase trouble-ticket resolution with automation, optimize component inventory management and enable efficient, consistent network operations. The IT team can now automate the base configurations for each site and deploy the network rapidly with Zero Touch Provisioning. Role-based access delegates tasks to local teams while maintaining central control, simplifying maintenance through a standardized network. The IT team can put users’ digital experiences first and reduce the IT workload across the entire network life cycle.
News Highlights:
- Juniper Mist Wireless (Wi-Fi) Assurance provides the fastest way to deploy and the easiest way to manage personalized Wi-Fi experiences, including up to 90 percent elimination in wireless trouble tickets, up to 85 percent fewer truck rolls and up to 9x faster deployment times in some instances. With Juniper, Nippon Gases’ Wi-Fi is fast, secure and reliable, even in the busiest, most experience-critical areas. For instance: reliable Wi-Fi supports seamless communication between industrial IoT devices, sensors and control systems, ensuring uninterrupted operations and real-time monitoring and enables technicians to access and update digital workflows or maintenance logs instantly.
- Juniper Mist Wired Assurance delivers reliable, secure connectivity experiences for stationary devices and IoT endpoints through AI-driven network operations.
- Juniper Networks® EX Series Switches enable unified visibility and control over both wireless and wired networking through a common Mist AI engine and microservices cloud infrastructure.
- Juniper’s Marvis™ Virtual Network Assistant is used across Nippon Gases’ wired and wireless domains to simplify and automate network operations. Acting as an extended member of the IT team, Marvis provides proactive actions and Self-Driving Network™ operations. It continuously optimizes the user experience and provides visibility into impending problems. As a result, IT operations have clear and secure visibility into user and application experiences. AIOps boosts network reliability with automated actions, optimizing the network in real time and enabling rapid troubleshooting when needed.
- A Juniper Enterprise Agreement (EA) gives Nippon Gases an easier way to purchase, consume and manage the portfolio of Juniper AI-Native Networking Platform software and support services anywhere in its business.
Supporting Quotes:
“Our business is incredibly dynamic and highly competitive. We are frequently building new factories, expanding our footprint and driving growth through acquisitions. These fast-paced changes mean IT typically has little lead time to support the new business demands that keep us ahead of the market. With Juniper’s AI-Native Networking Platform, we can rapidly yet easily deploy networks at new sites, ensuring seamless, secure connectivity and operational readiness. Juniper’s innovative solutions allow us to scale efficiently and consistently, meet business needs on tight timelines, and maintain the high standards our customers expect of a market leader.”
- Bjorn Dupont, IT Network Manager, Nippon Gases
“Nippon Gases needed to harmonize its complex network infrastructure to improve stability and support quality control. Centralized management was a particular challenge, as IT teams had to manage network devices individually across multiple countries. Simplifying network provisioning and operations therefore became a top priority. This requirement plays to our AI-Native Networking Platform’s strengths—offering insight-driven and automated solutions to mitigate manual, decentralized management. With Juniper, Nippon Gases can quickly identify, monitor and correlate network events in real time, proactively addressing potential issues before they impact operations and experiences.”
- Gos Hein van de Wouw, Vice President, Enterprise Sales, EMEA, Juniper Networks
About Juniper Networks
Juniper Networks believes that connectivity is not the same as experiencing a great connection. Juniper's AI-Native Networking Platform is built from the ground up to leverage AI to deliver the best and most secure user experiences from the edge to the data center and cloud. Additional information can be found at Juniper Networks (www.juniper.net) or connect with Juniper on X (Twitter), LinkedIn, and Facebook.
Juniper Networks, the Juniper Networks logo, Juniper, Junos, and other trademarks listed here are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241212532821/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom